Company intelligence / Profile preview

Laclarée

Lyon or Villeurbanne, Francelaclaree-vision.com ↗

Ownership: Private
Development stage: Other

Overview

Laclarée has developed a fully functional portable demonstrator for its adaptive eyeglasses, enabling small-scale trials with presbyopic individuals. The product uses a disruptive fluid-filled doublet-lens system activated by low-power microfluidic actuators and an infrared distance sensor to provide clear vision at all distances without compromising aesthetics. The company has raised seed funding and is progressing toward commercialization[4][7].

Therapeutic areas: Ophthalmology
Modalities: Device (specifically, adaptive eyeglasses with microfluidic and optical technologies)
Industry: Assistive Medical Devices

Partnerships

Kreaxi (seed investor)High-Tech Gründerfonds (HTGF) (seed investor)

Beyond the preview

Go deeper on Laclarée.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laclarée.

Explore the full profile